Tuesday Aug 5
ChemoCentryx, Inc. Announces Financial Results For The Second Quarter Ended June 30, 2014
ChemoCentryx, Inc., , a clinical-stage biopharmaceutical company focused on autoimmune diseases, inflammatory disorders and cancer, announced today its financial results for the second quarter ended June 30, 2014.
ChemoCentryx, Inc. To Hold Second Quarter 2014 Financial Results...
ChemoCentryx, Inc. announced today that the Company's second quarter 2014 financial results will be released after market close on Tuesday, August 5, 2014.